We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 Update.
- Authors
Martin, M A; Hoffman, J M; Freimuth, R R; Klein, T E; Dong, B J; Pirmohamed, M; Hicks, J K; Wilkinson, M R; Haas, D W; Kroetz, D L
- Abstract
The Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Abacavir Dosing were originally published in April 2012. We reviewed recent literature and concluded that none of the evidence would change the therapeutic recommendations in the original guideline; therefore, the original publication remains clinically current. However, we have updated the Supplementary Material online and included additional resources for applying CPIC guidelines to the electronic health record. Up-to-date information can be found at PharmGKB (http://www.pharmgkb.org).
- Subjects
PHARMACOGENOMICS; HLA histocompatibility antigens; ABACAVIR; DRUG dosage; LITERATURE reviews; ELECTRONIC health records
- Publication
Clinical Pharmacology & Therapeutics, 2014, Vol 95, Issue 5, p499
- ISSN
0009-9236
- Publication type
Article
- DOI
10.1038/clpt.2014.38